1. M. Benetkiewicz, A. Idbaih, P. Y. Cousin, B. Boisselier, Y. Marie, E. Criniere, K. Hoang-Xuan, J. Y. Delattre, M. Sanson, and O. Delattre. NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas. PLoS ONE, 4(1):e4107, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Base Sequence, *Brain Neoplasms/genetics/metabolism, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, *Gene Rearrangement, Humans, Molecular Sequence Data, *Mutation, *Oligodendroglioma/genetics/metabolism, Oligonucleotide Array Sequence Analysis, Receptor, Notch2/*genetics/metabolism, *Translocation, Genetic.



2. F. Ducray, E. Criniere, A. Idbaih, K. Mokhtari, Y. Marie, S. Paris, S. Navarro, F. Laigle-Donadey, C. Dehais, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. alpha-Internexin expression identifies 1p19q codeleted gliomas. Neurology, 72(2):156-61, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/diagnosis/*genetics, Chromosomes, Human, Pair 1/*genetics, Chromosomes, Human, Pair 19/*genetics, DNA Mutational Analysis, Disease Progression, Gene Deletion, Genes, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Glioma/diagnosis/*genetics, Humans, Intermediate Filament Proteins/*genetics, Mutation/genetics, Oligodendroglioma/diagnosis/genetics, Predictive Value of Tests, Prognosis.



3. F. Ducray, S. El Hallani, and A. Idbaih. Diagnostic and prognostic markers in gliomas. Curr Opin Oncol, 21(6):537-42, 2009. Note: Journal ArticleUnited States. [WWW]



4. S. El Hallani, B. Boisselier, Y. Marie, S. Paris, A. Idbaih, C. Carpentier, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 mutations but no CHEK2 *1100DelC variant in familial gliomas. Cancer Genet Cytogenet, 188(2):126-8, 2009. Note: LetterUnited States. [WWW] Keyword(s): Family, Female, Genetic Variation, Germ-Line Mutation, Glioma/*genetics, Humans, Male, *Mutation, Protein-Serine-Threonine Kinases/*genetics, *Sequence Deletion, Tumor Suppressor Protein p53/*genetics.



5. S. El Hallani, F. Ducray, A. Idbaih, Y. Marie, B. Boisselier, C. Colin, F. Laigle-Donadey, M. Rodero, O. Chinot, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology, 72(4):332-6, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Age of Onset, Aged, Aged, 80 and over, Codon/blood/*genetics, Female, Follow-Up Studies, Gene Frequency/genetics, Genetic Variation/genetics, Glioblastoma/blood/epidemiology/*genetics, Humans, Male, Middle Aged, Mutation/genetics, Polymorphism, Single Nucleotide/*genetics, Tumor Suppressor Protein p53/blood/*genetics, Young Adult.



6. A. Idbaih, J. Aimard, B. Boisselier, Y. Marie, S. Paris, E. Criniere, R. Carvalho Silva, F. Laigle-Donadey, A. Rousseau, K. Mokhtari, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol, 35(2):208-13, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Age of Onset, Brain Neoplasms/chemistry/*genetics, DNA Mutational Analysis, Female, Gene Expression, Glioblastoma/chemistry/*genetics, Humans, Male, Mutation, Missense, Protein Structure, Quaternary, Protein Structure, Tertiary, Receptor, Epidermal Growth Factor/chemistry/*genetics, Sex Characteristics.



7. A. Idbaih, E. Criniere, K. L. Ligon, O. Delattre, and J. Y. Delattre. Array-Based Genomics in Glioma Research. Brain Pathol, 2009. Note: Journal article. [WWW]



8. A. Rousseau, A. Idbaih, F. Ducray, E. Criniere, M. Fevre-Montange, A. Jouvet, and J. Y. Delattre. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol, 2009. Note: Journal article. [WWW]



9. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J. Y. Delattre. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 27(25):4150-4, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms/enzymology/*genetics/mortality/pathology/therapy, Codon, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Disease-Free Survival, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glioma/enzymology/*genetics/mortality/pathology/therapy, Humans, Isocitrate Dehydrogenase/*genetics, Kaplan-Meiers Estimate, Male, Middle Aged, *Mutation, Neoplasm Staging, Promoter Regions, Genetic, Proportional Hazards Models, Risk Assessment, Time Factors, Treatment Outcome, Tumor Markers, Biological/*genetics, Tumor Suppressor Proteins/genetics, Young Adult.



10. S. Shete, F. J. Hosking, L. B. Robertson, S. E. Dobbins, M. Sanson, B. Malmer, M. Simon, Y. Marie, B. Boisselier, J. Y. Delattre, K. Hoang-Xuan, S. El Hallani, A. Idbaih, D. Zelenika, U. Andersson, R. Henriksson, A. T. Bergenheim, M. Feychting, S. Lonn, A. Ahlbom, J. Schramm, M. Linnebank, K. Hemminki, R. Kumar, S. J. Hepworth, A. Price, G. Armstrong, Y. Liu, X. Gu, R. Yu, C. Lau, M. Schoemaker, K. Muir, A. Swerdlow, M. Lathrop, M. Bondy, and R. S. Houlston. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet, 41(8):899-904, 2009. Note: 5R01 CA070917/CA/NCI NIH HHS/United States5R01 CA119215/CA/NCI NIH HHS/United StatesC1298/A8362/Cancer Research UK/United KingdomR01 CA119215/CA/NCI NIH HHS/United StatesWellcome Trust/United KingdomJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Alleles, *Genetic Predisposition to Disease, *Genome-Wide Association Study, Glioma/*genetics, Humans, Linkage Disequilibrium/genetics, Polymorphism, Single Nucleotide/genetics, Reproducibility of Results.



11. F. Ducray, A. Benouaich-Amiel, A. Idbaih, A. Rousseau, F. Laigle-Donadey, J. Y. Delattre, and M. Sanson. Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. J Neurooncol, 88(2):185-8, 2008. Note: Case ReportsJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Brain Neoplasms/complications/*drug therapy/genetics/pathology, Chromosome Deletion, Chromosomes, Human, X/genetics, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/*analogs & derivatives/therapeutic use, Female, Glioblastoma/complications/*drug therapy/genetics/pathology, Humans, Tomography, X-Ray Computed, Tumor Suppressor Proteins/genetics.



12. F. Ducray, A. Idbaih, A. de Reynies, I. Bieche, J. Thillet, K. Mokhtari, S. Lair, Y. Marie, S. Paris, M. Vidaud, K. Hoang-Xuan, O. Delattre, J. Y. Delattre, and M. Sanson. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer, 7:41, 2008. Note: Journal ArticleEngland. [WWW]



13. R. Guillevin, C. Menuel, H. Duffau, M. Kujas, L. Capelle, A. Aubert, S. Taillibert, A. Idbaih, J. Pallud, G. Demarco, R. Costalat, K. Hoang-Xuan, J. Chiras, and J. N. Vallee. Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. J Neurooncol, 87(2):181-7, 2008. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*diagnosis, *Cell Proliferation, Female, Glioma/*diagnosis, Humans, Immunohistochemistry, Ki-67 Antigen/metabolism, *Magnetic Resonance Spectroscopy, Male, Middle Aged, Protons/*diagnostic use.



14. A. Idbaih, B. Boisselier, Y. Marie, M. Sanson, S. El Hallani, E. Criniere, M. Fourtassi, S. Paris, C. Carpentier, A. Rousseau, K. Mokhtari, C. Combadiere, F. Laigle-Donadey, K. Hoang-Xuan, and J. Y. Delattre. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Res, 1198:16-20, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Brain Neoplasms/*genetics/metabolism/physiopathology, Chromosomes, Human, Pair 1/genetics, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Humans, Male, Middle Aged, Oligodendroglioma/*genetics/metabolism/physiopathology, Phenotype, Polymorphism, Single Nucleotide/*genetics, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Retrospective Studies, Survival Rate, Tumor Suppressor Protein p53/*genetics.



15. A. Idbaih, R. Carvalho Silva, E. Criniere, Y. Marie, C. Carpentier, B. Boisselier, S. Taillibert, A. Rousseau, K. Mokhtari, F. Ducray, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Genomic changes in progression of low-grade gliomas. J Neurooncol, 90(2):133-40, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Chromosome Deletion, Chromosomes, Disease Progression, Female, Genome/*genetics, Glioma/*genetics/*metabolism, Humans, Male, Microsatellite Repeats, Middle Aged, Nucleic Acid Hybridization/methods.



16. A. Idbaih, E. Criniere, Y. Marie, A. Rousseau, K. Mokhtari, M. Kujas, Y. El Houfi, C. Carpentier, S. Paris, B. Boisselier, F. Laigle-Donadey, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro Oncol, 10(4):540-7, 2008. Note: Journal ArticleUnited States. [WWW]



17. A. Idbaih, M. Kouwenhoven, J. Jeuken, C. Carpentier, T. Gorlia, J. M. Kros, P. French, J. L. Teepen, O. Delattre, J. Y. Delattre, M. van den Bent, and K. Hoang-Xuan. Chromosome 1p loss evaluation in anaplastic oligodendrogliomas. Neuropathology, 28(4):440-3, 2008. Note: Case ReportsJournal ArticleResearch Support, Non-U.S. Gov'tAustraliaofficial journal of the Japanese Society of Neuropathology. [WWW] Keyword(s): Brain Neoplasms/*genetics, *Chromosome Deletion, Chromosomes, Artificial, Bacterial, Chromosomes, Human, Pair 1/*genetics, Humans, In Situ Hybridization, Fluorescence, Middle Aged, Nucleic Acid Hybridization/*methods, Oligodendroglioma/*genetics, Tumor Markers, Biological/genetics.



18. A. Idbaih, Y. Marie, C. Lucchesi, G. Pierron, E. Manie, V. Raynal, V. Mosseri, K. Hoang-Xuan, M. Kujas, I. Brito, K. Mokhtari, M. Sanson, E. Barillot, A. Aurias, J. Y. Delattre, and O. Delattre. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer, 122(8):1778-86, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Astrocytoma/genetics/pathology, Brain Neoplasms/classification/*genetics/*pathology, *Chromosome Deletion, Chromosomes, Artificial, Bacterial, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Chromosomes, Human, Pair 19, Chromosomes, Human, Pair 7, Chromosomes, Human, Pair 9, Disease-Free Survival, Female, Glioma/classification/*genetics/*pathology, Humans, Loss of Heterozygosity, Male, Middle Aged, Multivariate Analysis, Nucleic Acid Hybridization, Oligodendroglioma/genetics/pathology, Oligonucleotides, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Receptor, Epidermal Growth Factor/*genetics, Survival Analysis, World Health Organization.



19. A. Idbaih, S. Paris, B. Boisselier, Y. Marie, M. Sanson, J. Thillet, K. Hoang-Xuan, and J. Y. Delattre. Mutational analysis of Rac2 in gliomas. J Neurooncol, 87(3):365-6, 2008. Note: LetterResearch Support, Non-U.S. Gov'tNetherlands. [WWW]



20. G. Kaloshi, S. Everhard, F. Laigle-Donadey, Y. Marie, S. Navarro, K. Mokhtari, A. Idbaih, F. Ducray, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology, 70(8):590-5, 2008. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Chromosome Mapping, *Chromosomes, Human, Pair 19, Cohort Studies, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/therapeutic use, Disease-Free Survival, Female, Genetic Markers/physiology, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/*genetics, O(6)-Methylguanine-DNA Methyltransferase/*metabolism, Prognosis, Retrospective Studies, Tumor Markers, Biological.



21. M. J. Ribeiro, A. Idbaih, C. Thomas, P. Remy, N. Martin-Duverneuil, Y. Samson, J. Donadieu, and K. Hoang-Xuan. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. J Neurol, 255(4):575-80, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tGermany. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain/pathology/physiopathology/radionuclide imaging, Brain Mapping/methods, Cerebellar Ataxia/etiology/physiopathology/radionuclide imaging, Cognition Disorders/etiology/physiopathology/radionuclide imaging, Diagnosis, Differential, Early Diagnosis, Female, Fluorodeoxyglucose F18/diagnostic use, Histiocytosis, Langerhans-Cell/*complications, Humans, Male, Middle Aged, Motor Neuron Disease/etiology/physiopathology/radionuclide imaging, Neurodegenerative Diseases/etiology/*physiopathology/*radionuclide imaging, Positron-Emission Tomography/*methods/standards, Predictive Value of Tests, Prognosis.



22. S. El Hallani, Y. Marie, A. Idbaih, M. Rodero, B. Boisselier, F. Laigle-Donadey, F. Ducray, J. Y. Delattre, and M. Sanson. No association of MDM2 SNP309 with risk of glioblastoma and prognosis. J Neurooncol, 85(3):241-4, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality/pathology, Case-Control Studies, Female, Gene Expression Regulation, Neoplastic/genetics, Genetic Predisposition to Disease, Glioblastoma/*genetics/mortality/pathology, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Reference Values, Risk Factors, Survival Analysis, Tumor Markers, Biological/*genetics.



23. A. Idbaih, B. Boisselier, M. Sanson, E. Criniere, S. Liva, Y. Marie, C. Carpentier, S. Paris, F. Laigle-Donadey, K. Mokhtari, M. Kujas, K. Hoang-Xuan, O. Delattre, and J. Y. Delattre. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas. Cancer Genet Cytogenet, 176(2):121-126, 2007. Note: Journal article. [WWW]



24. A. Idbaih, A. Burlet, H. Adle-Biassette, R. Boisgard, C. Coulon, S. Paris, Y. Marie, J. Donadieu, K. Hoang-Xuan, and M. J. Ribeiro. Altered cerebral glucose metabolism in an animal model of diabetes insipidus: a micro-PET study. Brain Res, 1158:164-8, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW]



25. A. Idbaih, M. Kouwenhoven, J. Jeuken, A. Carpentier, T. Gorlia, M. Kros, P. French, O. Delattre, J. Y. Delattre, M. J. Van den Bent, and K. Hoang-Xuan. ``True and false''1p/19q codeletions in anaplastic oligodendrogial tumors. Neuropathology, pp sous-presse, 2007.



26. A. Idbaih, A. Omuro, F. Ducray, and K. Hoang-Xuan. Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol, 19(6):606-11, 2007. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Antineoplastic Agents/*therapeutic use, Brain Neoplasms/*drug therapy/*genetics/metabolism, Chromosome Deletion, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, *Gene Expression Regulation, Neoplastic, Glioma/*drug therapy/*genetics/metabolism, Humans, O(6)-Methylguanine-DNA Methyltransferase/genetics, Pharmacogenetics, Prognosis, Treatment Outcome, Tumor Markers, Biological/*biosynthesis/genetics.



27. G. Kaloshi, A. Benouaich-Amiel, F. Diakite, S. Taillibert, J. Lejeune, F. Laigle-Donadey, M. A. Renard, W. Iraqi, A. Idbaih, S. Paris, L. Capelle, H. Duffau, P. Cornu, J. M. Simon, K. Mokhtari, M. Polivka, A. Omuro, A. Carpentier, M. Sanson, J. Y. Delattre, and K. Hoang-Xuan. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology, 68(21):1831-6, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/*drug therapy/*genetics/physiopathology, *Chromosome Deletion, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, Dacarbazine/administration & dosage/*analogs & derivatives, Drug Resistance, Neoplasm/*genetics, Female, Gene Expression Regulation, Neoplastic/drug effects/genetics, Genetic Screening, Genotype, Glioma/*drug therapy/*genetics/physiopathology, Humans, Loss of Heterozygosity/genetics, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy/genetics, Retrospective Studies, Survival Rate, Treatment Outcome.



28. N. Auger, J. Thillet, K. Wanherdrick, A. Idbaih, M. E. Legrier, B. Dutrillaux, M. Sanson, and M. F. Poupon. Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line. Mol Cancer Ther, 5(9):2182-92, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Antineoplastic Agents, Alkylating/pharmacokinetics/*pharmacology, Cell Line, Tumor, Dacarbazine/*analogs & derivatives/pharmacokinetics/pharmacology, Drug Resistance, Neoplasm/genetics, Gene Expression, Glioma/*drug therapy/*genetics/metabolism, Humans, In Situ Hybridization, Fluorescence/methods, Karyotyping/methods, O(6)-Methylguanine-DNA Methyltransferase/biosynthesis/genetics, RNA, Messenger/biosynthesis/genetics.



29. N. Martin-Duverneuil, A. Idbaih, K. Hoang-Xuan, J. Donadieu, T. Genereau, R. Guillevin, and J. Chiras. MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol, 16(9):2074-82, 2006. Note: French Langerhans Cell Histiocytosis Study GroupJournal ArticleGermany. [WWW]



30. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, M. Kujas, K. Mokhtari, M. Sanson, J. Lejeune, A. Aurias, O. Delattre, and J. Y. Delattre. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol, 58(3):483-7, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/classification/*genetics, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Female, Gene Expression Profiling, Glioma/classification/*genetics, Humans, Loss of Heterozygosity, Male, Middle Aged.



31. A. Idbaih, J. Donadieu, M. A. Barthez, F. Geissmann, Y. Bertrand, O. Hermine, L. Brugieres, T. Genereau, C. Thomas, and K. Hoang-Xuan. Retinoic acid therapy in ``degenerative-like'' neuro-langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer, 43(1):55-8, 2004. Note: Clinical TrialJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Antineoplastic Agents/*therapeutic use, Cerebellar Ataxia/*drug therapy/etiology, Child, Female, Histiocytosis, Langerhans-Cell/complications/*drug therapy, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Tretinoin/*therapeutic use.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html